Neuropharmacological Actions of Metformin in Stroke

Increasing epidemiologic evidence suggests that metformin, a well-established AMPK activator and the most favorable first-line anti-diabetic drug, reduces stroke incidence and severity. However, the mechanism for this remains unclear. Moreover, previous experimental studies have reported controversi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Jia, Cheng, Jian, Ni, Jingshu, Zhen, Xuechu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812800/
https://www.ncbi.nlm.nih.gov/pubmed/26411966
http://dx.doi.org/10.2174/1570159X13666150205143555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812800/
https://www.ncbi.nlm.nih.gov/pubmed/26411966
http://dx.doi.org/10.2174/1570159X13666150205143555

Ejemplares similares